Clinical Development Of Bird Flu Vaccines For Pre-Pandemic Uses To Be Discussed By Cmte.
This article was originally published in PharmAsia News
Executive Summary
FDA's Vaccines and Related Biological Products Advisory Committee will discuss approval standards for pandemic influenza vaccines for use in a pre-pandemic setting during a Feb. 27 meeting
You may also be interested in...
HHS Boosts Pandemic Flu Vaccine Stockpile With Contracts Totaling $200 Mil.
Sanofi Pasteur, Novartis and GlaxoSmithKline stand to benefit from government's goal of adding 5.3 mil. doses to national stockpile.
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).